speb/financial-data huggingface dataset:
XE income_statement (quarterly, 2025-03-31) — Gross Profit: -11633000.00
XE income_statement (quarterly, 2025-03-31) — Interest Expense: 124000.00
XE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 124000.00
XE income_statement (quarterly, 2025-03-31) — Interest Income: 5477000.00
XE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 5477000.00
XE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1711000.00
XE cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 53424000.00
XE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -2525000.00
XE income_statement (quarterly, 2025-03-31) — Net Income: -10212000.00
XE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -10212000.00
XE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -10212000.00
XE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -10212000.00
XE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -10212000.00
XE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -10212000.00
XE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -10212000.00
XE income_statement (quarterly, 2025-03-31) — Net Interest Income: 5353000.00
XE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
XE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 5353000.00
XE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -16000.00
XE cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 9514000.00
XE cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: 53424000.00
XE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -20991000.00
XE income_statement (quarterly, 2025-03-31) — Normalized Income: -21341000.00
XE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -41860000.00
XE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -10968000.00
XE income_statement (quarterly, 2025-03-31) — Operating Income: -26302000.00
XE income_statement (quarterly, 2025-03-31) — Operating Revenue: 17091000.00
XE income_statement (quarterly, 2025-03-31) — Other Income Expense: 10737000.00
XE income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -392000.00
XE income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -3713000.00
XE cash_flow (quarterly, 2025-03-31) — Preferred Stock Issuance: 53424000.00
XE income_statement (quarterly, 2025-03-31) — Pretax Income: -10212000.00
XE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
XE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 28724000.00
XE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 226000.00
XE cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -2525000.00
XE income_statement (quarterly, 2025-03-31) — Research And Development: 402000.00
XE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
XE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 17980000.00
XE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 65000.00
XE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
XE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
XE income_statement (quarterly, 2025-03-31) — Total Expenses: 43393000.00
XE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -26302000.00
XE income_statement (quarterly, 2025-03-31) — Total Unusual Items: 11129000.00
XE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 11129000.00
XE cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 387000.00
XE income_statement (annual, 2025-12-31) — +Operating Expense: 141196000.00
XE income_statement (annual, 2025-12-31) — +Total Revenue: 94260000.00
XE balance_sheet (annual, 2025-12-31) — Accounts Payable: 3363000.00
XE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 32940000.00
XE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1457217000.00
XE cash_flow (annual, 2025-12-31) — Amortization Of Securities: -277000.00
XE income_statement (annual, 2025-12-31) — Basic Average Shares: 273442494.00
XE income_statement (annual, 2025-12-31) — Basic EPS: -0.54
XE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 514600000.00
XE cash_flow (annual, 2025-12-31) — Capital Expenditure: -117236000.00
XE cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -117236000.00
XE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 20887000.00
XE balance_sheet (annual, 2025-12-31) — Capital Stock: 39000.00
XE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1408967000.00
XE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1713875000.00
XE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 726130000.00
XE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -628344000.00
XE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -149860000.00
XE cash_flow (annual, 2025-12-31) — Change In Account Payable: 8736000.00
XE cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 0.00
XE cash_flow (annual, 2025-12-31) — Change In Interest Payable: 0.00
XE cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -18180000.00
XE cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -3334000.00
XE cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 15153000.00
XE cash_flow (annual, 2025-12-31) — Change In Payable: 4481000.00
XE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 4481000.00
XE cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -4026000.00
XE cash_flow (annual, 2025-12-31) — Change In Receivables: -10971000.00
XE cash_flow (annual, 2025-12-31) — Change In Working Capital: -16877000.00
XE cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -24804000.00
XE cash_flow (annual, 2025-12-31) — Changes In Cash: -52074000.00
XE balance_sheet (annual, 2025-12-31) — Common Stock: 39000.00
XE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1439923000.00
XE cash_flow (annual, 2025-12-31) — Common Stock Payments: -25274000.00
XE income_statement (annual, 2025-12-31) — Cost Of Revenue: 169964000.00
XE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 48291000.00
XE balance_sheet (annual, 2025-12-31) — Current Assets: 1800473000.00
XE balance_sheet (annual, 2025-12-31) — Current Liabilities: 55879000.00
XE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1390000.00
XE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1390000.00
XE balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 0.00
XE income_statement (annual, 2025-12-31) — Diluted Average Shares: 273442494.00
XE income_statement (annual, 2025-12-31) — Diluted EPS: -0.54
XE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -142155000.00
XE balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 4580000.00
XE balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 4225000.00
XE income_statement (annual, 2025-12-31) — EBIT: -212376000.00
XE income_statement (annual, 2025-12-31) — EBITDA: -210986000.00
XE cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 104000.00
XE cash_flow (annual, 2025-12-31) — End Cash Position: 462630000.00
XE cash_flow (annual, 2025-12-31) — Financing Cash Flow: 726130000.00
XE cash_flow (annual, 2025-12-31) — Free Cash Flow: -267096000.00
XE cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 223532000.00
XE balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -117000.00
XE balance_sheet (annual, 2025-12-31) — Gross PPE: 73434000.00
XE income_statement (annual, 2025-12-31) — Gross Profit: -75704000.00
XE income_statement (annual, 2025-12-31) — Interest Expense: 475000.00
XE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 475000.00
XE income_statement (annual, 2025-12-31) — Interest Income: 20293000.00
XE income_statement (annual, 2025-12-31) — Interest Income Non Operating: 20293000.00
XE cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 0.00
XE balance_sheet (annual, 2025-12-31) — Invested Capital: 1439923000.00
XE cash_flow (annual, 2025-12-31) — Investing Cash Flow: -628344000.00
XE balance_sheet (annual, 2025-12-31) — Investments And Advances: 261458000.00
XE cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 752924000.00
XE cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
XE balance_sheet (annual, 2025-12-31) — Limited Partnership Capital: 0.00
XE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 20887000.00
XE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 20887000.00
XE balance_sheet (annual, 2025-12-31) — Minority Interest: 626155000.00
XE income_statement (annual, 2025-12-31) — Minority Interests: 70696000.00
XE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -25274000.00
XE income_statement (annual, 2025-12-31) — Net Income: -142155000.00
XE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -142155000.00
XE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -212851000.00
XE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -142155000.00
XE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -142155000.00
XE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -389778000.00
XE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -212851000.00
XE income_statement (annual, 2025-12-31) — Net Interest Income: 19818000.00
XE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -565946000.00
XE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
XE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 19818000.00
XE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1520000.00
XE cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 54838000.00
XE balance_sheet (annual, 2025-12-31) — Net PPE: 73434000.00
XE cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 752924000.00
XE cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
XE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1439923000.00
XE balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 15153000.00
XE balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 15153000.00
XE income_statement (annual, 2025-12-31) — Normalized EBITDA: -210986000.00
XE income_statement (annual, 2025-12-31) — Normalized Income: -142155000.00
XE cash_flow (annual, 2025-12-31) — Operating Cash Flow: -149860000.00
XE cash_flow (annual, 2025-12-31) — Operating Gains Losses: 223532000.00
XE income_statement (annual, 2025-12-31) — Operating Income: -216900000.00
XE income_statement (annual, 2025-12-31) — Operating Revenue: 94260000.00
XE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 273442494.00
XE balance_sheet (annual, 2025-12-31) — Other Current Assets: 7549000.00
XE balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -117000.00
XE income_statement (annual, 2025-12-31) — Other Income Expense: -15769000.00
XE cash_flow (annual, 2025-12-31) — Other Non Cash Items: 4998000.00
XE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 22632000.00
XE income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -15769000.00
XE income_statement (annual, 2025-12-31) — Other Operating Expenses: -14838000.00
XE balance_sheet (annual, 2025-12-31) — Other Properties: 73434000.00
XE balance_sheet (annual, 2025-12-31) — Other Receivables: 41529000.00
XE balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 304908000.00
XE balance_sheet (annual, 2025-12-31) — Payables: 7588000.00
XE balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 55879000.00
XE balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 0.00
XE cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 752924000.00
XE income_statement (annual, 2025-12-31) — Pretax Income: -212851000.00
XE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -565946000.00
XE balance_sheet (annual, 2025-12-31) — Receivables: 79049000.00
XE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 169964000.00
XE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1390000.00
XE cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
XE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -25274000.00
XE income_statement (annual, 2025-12-31) — Research And Development: 1708000.00
XE balance_sheet (annual, 2025-12-31) — Retained Earnings: -17216000.00
XE income_statement (annual, 2025-12-31) — Selling General And Administration: 154326000.00
XE balance_sheet (annual, 2025-12-31) — Share Issued: 273442494.00
XE cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 0.00
XE cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
XE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 14137000.00
XE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1439923000.00
XE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1439923000.00
XE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
XE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
XE balance_sheet (annual, 2025-12-31) — Total Assets: 2157997000.00
XE balance_sheet (annual, 2025-12-31) — Total Capitalization: 1439923000.00
XE balance_sheet (annual, 2025-12-31) — Total Debt: 20887000.00
XE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2066078000.00
XE income_statement (annual, 2025-12-31) — Total Expenses: 311160000.00
XE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 91919000.00
XE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 357524000.00
XE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 36040000.00
XE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -216900000.00
XE balance_sheet (annual, 2025-12-31) — Total Partnership Capital: 0.00
XE cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 13015000.00
XE balance_sheet (annual, 2025-12-31) — Working Capital: 1744594000.00
XE income_statement (quarterly, 2026-03-31) — +Operating Expense: 40655000.00
XE income_statement (quarterly, 2026-03-31) — +Total Revenue: 39906000.00
XE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 10036000.00
XE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 21962000.00
XE balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -4039000.00
XE cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -1122000.00
XE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 273442494.00
XE income_statement (quarterly, 2026-03-31) — Basic EPS: -0.61
XE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 462630000.00
XE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -42967000.00
XE cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -42967000.00
XE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 27360000.00
XE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 224076000.00
XE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 673585000.00
XE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1050000.00
XE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -166007000.00
XE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -67252000.00
XE cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 13621000.00
XE cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -653000.00
XE cash_flow (quarterly, 2026-03-31) — Change In Interest Payable: -653000.00
XE cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -31201000.00
XE cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 473000.00
XE cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 2892000.00
XE cash_flow (quarterly, 2026-03-31) — Change In Payable: 13693000.00
XE cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 13040000.00
XE cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -7118000.00
XE cash_flow (quarterly, 2026-03-31) — Change In Receivables: 8386000.00
XE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -13528000.00
XE cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 5293000.00
XE cash_flow (quarterly, 2026-03-31) — Changes In Cash: -234309000.00
XE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -1290636000.00
XE cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
XE balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 66345000.00
XE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 65359000.00
XE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 67539000.00
XE balance_sheet (quarterly, 2026-03-31) — Current Assets: 774381000.00
XE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 2571000.00
XE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2571000.00
XE balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 3835000.00
XE balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 3835000.00
XE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 89348000.00
XE balance_sheet (quarterly, 2026-03-31) — Current Provisions: 1068000.00
XE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 451000.00
XE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 451000.00
XE balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 17898000.00
XE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 273442494.00
XE income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.61
XE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -166217000.00
XE balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 4182000.00
XE balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 4299000.00
XE income_statement (quarterly, 2026-03-31) — EBIT: -166217000.00
XE income_statement (quarterly, 2026-03-31) — EBITDA: -165766000.00
XE cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -35000.00
XE cash_flow (quarterly, 2026-03-31) — End Cash Position: 228286000.00
XE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1050000.00
XE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -110219000.00
XE cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 108899000.00
XE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -109018000.00
XE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 26000.00
XE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 100888000.00
XE income_statement (quarterly, 2026-03-31) — Gross Profit: -25453000.00
XE income_statement (quarterly, 2026-03-31) — Interest Expense: 0.00
XE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 0.00
XE income_statement (quarterly, 2026-03-31) — Interest Income: 8929000.00
XE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 8929000.00
XE balance_sheet (quarterly, 2026-03-31) — Invested Capital: -1290636000.00
XE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -166007000.00
XE balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 270438000.00
XE cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 500000.00
XE balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 1697000.00
XE balance_sheet (quarterly, 2026-03-31) — Leases: 1879000.00
XE balance_sheet (quarterly, 2026-03-31) — Limited Partnership Capital: 95341000.00
XE balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 24789000.00
XE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 24789000.00
XE balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 5164000.00
XE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
XE income_statement (quarterly, 2026-03-31) — Net Income: -166217000.00
XE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -166217000.00
XE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -166217000.00
XE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -166217000.00
XE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -166217000.00
XE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -166217000.00
XE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -166217000.00
XE income_statement (quarterly, 2026-03-31) — Net Interest Income: 8929000.00
XE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -151806000.00
XE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 8929000.00
XE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1550000.00
XE cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 28766000.00
XE balance_sheet (quarterly, 2026-03-31) — Net PPE: 96849000.00
XE cash_flow (quarterly, 2026-03-31) — Net Preferred Stock Issuance: 500000.00
XE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -626155000.00
XE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 18045000.00
XE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 18045000.00
XE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -56748000.00
XE income_statement (quarterly, 2026-03-31) — Normalized Income: -57199000.00
XE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -67252000.00
XE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 108899000.00
XE income_statement (quarterly, 2026-03-31) — Operating Income: -66108000.00
XE income_statement (quarterly, 2026-03-31) — Operating Revenue: 39906000.00
XE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 273442494.00
XE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 23493000.00
XE balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 16559000.00
XE income_statement (quarterly, 2026-03-31) — Other Income Expense: -109038000.00
XE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 54344000.00
XE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -20000.00
XE income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -3517000.00
XE balance_sheet (quarterly, 2026-03-31) — Other Properties: 25803000.00
XE balance_sheet (quarterly, 2026-03-31) — Other Receivables: 51159000.00
XE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 449509000.00
XE balance_sheet (quarterly, 2026-03-31) — Payables: 14335000.00
XE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 81874000.00
XE balance_sheet (quarterly, 2026-03-31) — Preferred Securities Outside Stock Equity: 2336568000.00
XE cash_flow (quarterly, 2026-03-31) — Preferred Stock Issuance: 500000.00
XE income_statement (quarterly, 2026-03-31) — Pretax Income: -166217000.00
XE balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
XE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -189906000.00
XE balance_sheet (quarterly, 2026-03-31) — Receivables: 77303000.00
XE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 65359000.00
XE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 451000.00
XE cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
XE income_statement (quarterly, 2026-03-31) — Research And Development: 55000.00
XE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1402562000.00
XE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 38100000.00
XE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 44117000.00
XE balance_sheet (quarterly, 2026-03-31) — Share Issued: 273442494.00
XE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 4265000.00
XE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -626155000.00
XE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -1290636000.00
XE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
XE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
XE balance_sheet (quarterly, 2026-03-31) — Total Assets: 1196012000.00
XE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -1916791000.00
XE balance_sheet (quarterly, 2026-03-31) — Total Debt: 27360000.00
XE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -1290636000.00
XE income_statement (quarterly, 2026-03-31) — Total Expenses: 106014000.00
XE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2486648000.00
XE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 421631000.00
XE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2397300000.00
XE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -66108000.00
XE balance_sheet (quarterly, 2026-03-31) — Total Partnership Capital: -1290636000.00
XE income_statement (quarterly, 2026-03-31) — Total Unusual Items: -109018000.00
XE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -109018000.00
XE cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 0.00
XE balance_sheet (quarterly, 2026-03-31) — Working Capital: 685033000.00
XEL cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -57000000.00
XEL cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
XEL balance_sheet (annual, 2021-12-31) — Prepaid Assets: 44000000.00
XEL cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
XEL income_statement (annual, 2021-12-31) — Total Other Finance Cost: 29000000.00
XEL income_statement (annual, 2022-12-31) — +Operating Expense: 3432000000.00
XEL income_statement (annual, 2022-12-31) — +Total Revenue: 15310000000.00
XEL balance_sheet (annual, 2022-12-31) — Accounts Payable: 1804000000.00
XEL balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1373000000.00
XEL balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -21103000000.00
XEL balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 8155000000.00
XEL balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -122000000.00
XEL income_statement (annual, 2022-12-31) — Basic Average Shares: 547000000.00
XEL income_statement (annual, 2022-12-31) — Basic EPS: 3.18
XEL cash_flow (annual, 2022-12-31) — Beginning Cash Position: 166000000.00
XEL cash_flow (annual, 2022-12-31) — Capital Expenditure: -4638000000.00
XEL cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -4638000000.00
XEL balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1255000000.00
XEL balance_sheet (annual, 2022-12-31) — Capital Stock: 1374000000.00
XEL balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 111000000.00
XEL balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 111000000.00
XEL cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -1012000000.00
XEL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 666000000.00
XEL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -4653000000.00
XEL cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 3932000000.00
XEL cash_flow (annual, 2022-12-31) — Change In Account Payable: 195000000.00
XEL cash_flow (annual, 2022-12-31) — Change In Inventory: -203000000.00
XEL cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -58000000.00
XEL cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 102000000.00
XEL cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 521000000.00
XEL cash_flow (annual, 2022-12-31) — Change In Payable: 195000000.00
XEL cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 195000000.00
XEL cash_flow (annual, 2022-12-31) — Change In Receivables: -672000000.00
XEL cash_flow (annual, 2022-12-31) — Change In Working Capital: -115000000.00
XEL cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -429000000.00
XEL cash_flow (annual, 2022-12-31) — Changes In Cash: -55000000.00
XEL balance_sheet (annual, 2022-12-31) — Common Stock: 1374000000.00
XEL cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -1012000000.00
XEL balance_sheet (annual, 2022-12-31) — Common Stock Equity: 16675000000.00
XEL cash_flow (annual, 2022-12-31) — Common Stock Issuance: 322000000.00
XEL balance_sheet (annual, 2022-12-31) — Construction In Progress: 2124000000.00
XEL income_statement (annual, 2022-12-31) — Cost Of Revenue: 9450000000.00
XEL balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 217000000.00
XEL balance_sheet (annual, 2022-12-31) — Current Assets: 5144000000.00
XEL balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 217000000.00
XEL balance_sheet (annual, 2022-12-31) — Current Debt: 1964000000.00
XEL balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 2181000000.00
XEL balance_sheet (annual, 2022-12-31) — Current Liabilities: 6078000000.00
XEL cash_flow (annual, 2022-12-31) — Deferred Income Tax: -140000000.00
XEL cash_flow (annual, 2022-12-31) — Deferred Tax: -140000000.00
XEL cash_flow (annual, 2022-12-31) — Depreciation: 2554000000.00
XEL cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 2554000000.00
XEL income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 2413000000.00
XEL cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2554000000.00
XEL income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 2413000000.00
XEL balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 113000000.00
XEL income_statement (annual, 2022-12-31) — Diluted Average Shares: 547000000.00
XEL income_statement (annual, 2022-12-31) — Diluted EPS: 3.17
XEL income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 1736000000.00
XEL cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 37000000.00
XEL balance_sheet (annual, 2022-12-31) — Dividends Payable: 268000000.00
XEL income_statement (annual, 2022-12-31) — EBIT: 2526000000.00
XEL income_statement (annual, 2022-12-31) — EBITDA: 5080000000.00
XEL income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 36000000.00
XEL cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -36000000.00
XEL balance_sheet (annual, 2022-12-31) — Employee Benefits: 390000000.00
XEL cash_flow (annual, 2022-12-31) — End Cash Position: 111000000.00
XEL balance_sheet (annual, 2022-12-31) — Financial Assets: 93000000.00
XEL cash_flow (annual, 2022-12-31) — Financing Cash Flow: 666000000.00
XEL cash_flow (annual, 2022-12-31) — Free Cash Flow: -706000000.00
XEL balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -93000000.00
XEL balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 1495000000.00
XEL balance_sheet (annual, 2022-12-31) — Gross PPE: 70560000000.00
XEL income_statement (annual, 2022-12-31) — Gross Profit: 5860000000.00
XEL balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 279000000.00
XEL cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 15000000.00
XEL income_statement (annual, 2022-12-31) — Interest Expense: 925000000.00
XEL income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 925000000.00
XEL cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 887000000.00
XEL balance_sheet (annual, 2022-12-31) — Interest Payable: 217000000.00
XEL balance_sheet (annual, 2022-12-31) — Inventory: 803000000.00
XEL balance_sheet (annual, 2022-12-31) — Invested Capital: 41452000000.00
XEL cash_flow (annual, 2022-12-31) — Investing Cash Flow: -4653000000.00
XEL balance_sheet (annual, 2022-12-31) — Investments And Advances: 3234000000.00
XEL cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 322000000.00
XEL cash_flow (annual, 2022-12-31) — Issuance Of Debt: 2164000000.00
XEL balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1038000000.00
XEL balance_sheet (annual, 2022-12-31) — Long Term Debt: 22813000000.00
XEL balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 23851000000.00
XEL cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 2164000000.00
XEL cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -601000000.00
XEL balance_sheet (annual, 2022-12-31) — Long Term Provisions: 3380000000.00
XEL cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
XEL cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 322000000.00
XEL balance_sheet (annual, 2022-12-31) — Net Debt: 24666000000.00
XEL income_statement (annual, 2022-12-31) — Net Income: 1736000000.00
XEL income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1736000000.00
XEL income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 1736000000.00
XEL income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1736000000.00
XEL income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 1736000000.00
XEL cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 1736000000.00
XEL income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 1736000000.00
XEL income_statement (annual, 2022-12-31) — Net Interest Income: -925000000.00
XEL cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -35000000.00
XEL cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 1371000000.00
XEL cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 1563000000.00
XEL income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -925000000.00
XEL cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -15000000.00
XEL cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 20000000.00
XEL balance_sheet (annual, 2022-12-31) — Net PPE: 49457000000.00
XEL cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -192000000.00
XEL balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 16675000000.00
XEL balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 4985000000.00
XEL balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 181000000.00
XEL balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 4804000000.00
XEL balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 390000000.00
XEL income_statement (annual, 2022-12-31) — Normalized EBITDA: 5005000000.00
XEL income_statement (annual, 2022-12-31) — Normalized Income: 1676750000.00
XEL cash_flow (annual, 2022-12-31) — Operating Cash Flow: 3932000000.00
XEL cash_flow (annual, 2022-12-31) — Operating Gains Losses: -36000000.00
XEL income_statement (annual, 2022-12-31) — Operating Income: 2428000000.00
XEL income_statement (annual, 2022-12-31) — Operating Revenue: 15203000000.00
XEL balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 549578018.00
XEL balance_sheet (annual, 2022-12-31) — Other Current Assets: 1419000000.00
XEL balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 1964000000.00
XEL balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1039000000.00
XEL balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -93000000.00
XEL income_statement (annual, 2022-12-31) — Other Income Expense: 98000000.00
XEL balance_sheet (annual, 2022-12-31) — Other Inventories: 272000000.00
XEL balance_sheet (annual, 2022-12-31) — Other Investments: 3234000000.00
XEL cash_flow (annual, 2022-12-31) — Other Non Cash Items: -197000000.00
XEL balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 389000000.00
XEL balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 147000000.00
XEL income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -13000000.00
XEL income_statement (annual, 2022-12-31) — Other Operating Expenses: 331000000.00
XEL balance_sheet (annual, 2022-12-31) — Other Properties: 4130000000.00
XEL income_statement (annual, 2022-12-31) — Other Special Charges: -75000000.00
XEL income_statement (annual, 2022-12-31) — Other Taxes: 688000000.00
XEL balance_sheet (annual, 2022-12-31) — Payables: 2641000000.00
XEL balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 2858000000.00
XEL balance_sheet (annual, 2022-12-31) — Prepaid Assets: 54000000.00
XEL income_statement (annual, 2022-12-31) — Pretax Income: 1601000000.00
XEL cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 73000000.00
XEL cash_flow (annual, 2022-12-31) — Purchase Of Investment: -1332000000.00
XEL balance_sheet (annual, 2022-12-31) — Receivables: 2478000000.00
XEL income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 9309000000.00
XEL income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2554000000.00
XEL cash_flow (annual, 2022-12-31) — Repayment Of Debt: -793000000.00
XEL income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
XEL balance_sheet (annual, 2022-12-31) — Retained Earnings: 7239000000.00
XEL cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
XEL cash_flow (annual, 2022-12-31) — Sale Of Investment: 1297000000.00
XEL balance_sheet (annual, 2022-12-31) — Share Issued: 549578018.00
XEL cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -192000000.00
XEL income_statement (annual, 2022-12-31) — Special Income Charges: 75000000.00
XEL cash_flow (annual, 2022-12-31) — Stock Based Compensation: 20000000.00
XEL balance_sheet (annual, 2022-12-31) — Stockholders Equity: 16675000000.00
XEL balance_sheet (annual, 2022-12-31) — Tangible Book Value: 16675000000.00
XEL income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 15750000.00
XEL income_statement (annual, 2022-12-31) — Tax Provision: -135000000.00
XEL income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
XEL balance_sheet (annual, 2022-12-31) — Total Assets: 61188000000.00
XEL balance_sheet (annual, 2022-12-31) — Total Capitalization: 39488000000.00
XEL balance_sheet (annual, 2022-12-31) — Total Debt: 26032000000.00
XEL balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 16675000000.00
XEL income_statement (annual, 2022-12-31) — Total Expenses: 12882000000.00
XEL balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 44513000000.00
XEL balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 56044000000.00
XEL balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 38435000000.00
XEL income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 2428000000.00
XEL income_statement (annual, 2022-12-31) — Total Other Finance Cost: 31000000.00
XEL balance_sheet (annual, 2022-12-31) — Total Tax Payable: 569000000.00
XEL income_statement (annual, 2022-12-31) — Total Unusual Items: 75000000.00
XEL income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 75000000.00
XEL balance_sheet (annual, 2022-12-31) — Working Capital: -934000000.00
XEL income_statement (annual, 2023-12-31) — +Operating Expense: 3391000000.00
XEL income_statement (annual, 2023-12-31) — +Total Revenue: 14206000000.00
XEL balance_sheet (annual, 2023-12-31) — Accounts Payable: 1668000000.00
XEL balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1315000000.00
XEL balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -22317000000.00
XEL balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 8465000000.00
XEL balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -128000000.00
XEL income_statement (annual, 2023-12-31) — Basic Average Shares: 552000000.00
XEL income_statement (annual, 2023-12-31) — Basic EPS: 3.21
XEL cash_flow (annual, 2023-12-31) — Beginning Cash Position: 111000000.00
XEL cash_flow (annual, 2023-12-31) — Capital Expenditure: -5854000000.00
XEL cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -5854000000.00
XEL balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1264000000.00
XEL balance_sheet (annual, 2023-12-31) — Capital Stock: 1387000000.00
XEL balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 129000000.00
XEL balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 129000000.00
XEL cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -1092000000.00
XEL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 617000000.00
XEL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -5926000000.00
XEL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 5327000000.00
XEL cash_flow (annual, 2023-12-31) — Change In Account Payable: -149000000.00
XEL cash_flow (annual, 2023-12-31) — Change In Inventory: -98000000.00
XEL cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 86000000.00
XEL cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 200000000.00
XEL cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 928000000.00
XEL cash_flow (annual, 2023-12-31) — Change In Payable: -149000000.00
XEL cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -149000000.00
XEL cash_flow (annual, 2023-12-31) — Change In Receivables: 225000000.00
XEL cash_flow (annual, 2023-12-31) — Change In Working Capital: 1192000000.00
XEL cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -27000000.00
XEL cash_flow (annual, 2023-12-31) — Changes In Cash: 18000000.00
XEL balance_sheet (annual, 2023-12-31) — Common Stock: 1387000000.00
XEL cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -1092000000.00
XEL balance_sheet (annual, 2023-12-31) — Common Stock Equity: 17616000000.00
XEL cash_flow (annual, 2023-12-31) — Common Stock Issuance: 270000000.00
XEL balance_sheet (annual, 2023-12-31) — Construction In Progress: 2873000000.00
XEL income_statement (annual, 2023-12-31) — Cost Of Revenue: 8227000000.00
XEL balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 251000000.00
XEL balance_sheet (annual, 2023-12-31) — Current Assets: 4069000000.00
XEL balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 226000000.00
XEL balance_sheet (annual, 2023-12-31) — Current Debt: 1337000000.00
XEL balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1563000000.00
XEL balance_sheet (annual, 2023-12-31) — Current Liabilities: 5652000000.00
XEL cash_flow (annual, 2023-12-31) — Deferred Income Tax: -59000000.00
XEL cash_flow (annual, 2023-12-31) — Deferred Tax: -59000000.00
XEL cash_flow (annual, 2023-12-31) — Depreciation: 2567000000.00
XEL cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2567000000.00
XEL income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 2448000000.00
XEL cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2567000000.00
XEL income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 2448000000.00
XEL balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 86000000.00
XEL income_statement (annual, 2023-12-31) — Diluted Average Shares: 552000000.00
XEL income_statement (annual, 2023-12-31) — Diluted EPS: 3.21
XEL income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 1771000000.00
XEL cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 35000000.00
XEL balance_sheet (annual, 2023-12-31) — Dividends Payable: 289000000.00
XEL income_statement (annual, 2023-12-31) — EBIT: 2629000000.00
XEL income_statement (annual, 2023-12-31) — EBITDA: 5196000000.00
XEL income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 35000000.00
XEL cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -35000000.00
XEL balance_sheet (annual, 2023-12-31) — Employee Benefits: 469000000.00
XEL cash_flow (annual, 2023-12-31) — End Cash Position: 129000000.00
XEL balance_sheet (annual, 2023-12-31) — Financial Assets: 76000000.00
XEL cash_flow (annual, 2023-12-31) — Financing Cash Flow: 617000000.00
XEL cash_flow (annual, 2023-12-31) — Free Cash Flow: -527000000.00
XEL balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -94000000.00
XEL balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 1443000000.00
XEL balance_sheet (annual, 2023-12-31) — Gross PPE: 75176000000.00
XEL income_statement (annual, 2023-12-31) — Gross Profit: 5979000000.00
XEL balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 104000000.00
XEL cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 12000000.00
XEL income_statement (annual, 2023-12-31) — Interest Expense: 1004000000.00
XEL income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1004000000.00
XEL cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 945000000.00
XEL balance_sheet (annual, 2023-12-31) — Interest Payable: 251000000.00
XEL balance_sheet (annual, 2023-12-31) — Inventory: 711000000.00
XEL balance_sheet (annual, 2023-12-31) — Invested Capital: 43866000000.00
XEL cash_flow (annual, 2023-12-31) — Investing Cash Flow: -5926000000.00
XEL balance_sheet (annual, 2023-12-31) — Investments And Advances: 3599000000.00
XEL cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 270000000.00
XEL cash_flow (annual, 2023-12-31) — Issuance Of Debt: 2630000000.00
XEL balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1038000000.00
XEL balance_sheet (annual, 2023-12-31) — Long Term Debt: 24913000000.00
XEL balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 25951000000.00
XEL cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 2630000000.00
XEL cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -1151000000.00
XEL balance_sheet (annual, 2023-12-31) — Long Term Provisions: 3218000000.00
XEL cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 270000000.00
XEL balance_sheet (annual, 2023-12-31) — Net Debt: 26121000000.00
XEL income_statement (annual, 2023-12-31) — Net Income: 1771000000.00
XEL income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 1771000000.00
XEL income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 1771000000.00
XEL income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 1771000000.00
XEL income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 1771000000.00
XEL cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 1771000000.00
XEL income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 1771000000.00
XEL income_statement (annual, 2023-12-31) — Net Interest Income: -1004000000.00
XEL cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -35000000.00
XEL cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 1451000000.00
XEL cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 1479000000.00
XEL income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -1004000000.00
XEL cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -12000000.00
XEL cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -37000000.00
XEL balance_sheet (annual, 2023-12-31) — Net PPE: 52859000000.00
XEL cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -28000000.00